0.6784  -0.123 (-15.33%)		10-03 16:00
Open: 0.7965 High: 0.8271 Volume: 3,014,595		Pre. Close: 0.8012 Low: 0.6401 Market Cap: 47(M)

Short term
Mid term
Targets	6-month :	1.52	1-year :	2
Resists	First :	1.3	Second :	1.72
Pivot price	1.07
Supports	First :	0.64	Second :	0.53
MAs	MA(5) :	0.83	MA(20) :	1.19
	MA(100) :	1.27	MA(250) :	0
MACD	MACD :	-0.2	Signal :	-0.1
%K %D	K(14,3) :	7.8	D(3) :	11.6
RSI	RSI(14): 30.9
52-week	High :	7.03	Low :	0.61

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ WGRX ] has closed above bottom band by 7.7%. Bollinger Bands are 13.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.83 - 0.84	0.84 - 0.85
Low:	0.63 - 0.63	0.63 - 0.64
Close:	0.67 - 0.68	0.68 - 0.69

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Fri, 03 Oct 2025
Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies - Florida Today

Fri, 03 Oct 2025
Wellgistics Health Inc Announces Successful Stock Offering - MSN

Tue, 30 Sep 2025
Wellgistics Partners with TheracosBio to Expand Brenzavvy Access to 6.5K Pharmacies | WGRX Stock News - Stock Titan

Tue, 30 Sep 2025
Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies - Lohud

Tue, 30 Sep 2025
Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies - USA Today

Tue, 30 Sep 2025
Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies - The Des Moines Register

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Distribution
Shares Out	0 (M)
Shares Float	91 (M)
Held by Insiders	1.254e+007 (%)
Held by Institutions	55.7 (%)
Shares Short	495 (K)
Shares Short P.Month	0 (K)

EPS	-3.963e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	-123.4 %
Operating Margin	-70.6 %
Return on Assets (ttm)	-90.7 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	17 %
Gross Profit (p.s.)	0.02
Sales Per Share	0.25
EBITDA (p.s.)	-0.07
Qtrly Earnings Growth	-0.8 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-5 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	2.68
Price to Cash Flow	0

Dividend	0
Forward Dividend	635660
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.